Michael R. Bishop, MD, is Professor of Medicine and Director of the David and Etta Jonas Center for Cellular Therapy at the University of Chicago. He specializes in the diagnosis and treatment of lymphomas. In particular, he cares for patients with advanced hematologic malignancies that have not responded to first-line treatments. His expertise is in hematopoietic stem cell transplantation (bone marrow transplantation) and cellular therapy.

Dr. Bishop's research focuses on the prevention and treatment of relapse after stem cell transplantation and cell therapy, which is the primary cause of treatment failure and death after these treatments. Specifically, he works on ways to enhance immune effects of cellular therapies against cancer.

An active contributor to medical literature, Dr. Bishop has authored more than 250 peer-reviewed articles and editorials and 30 book chapters, and edited two books on cancer treatment and research. Since 2001, Dr. Bishop has consistently been named one of the "Best Doctors in America" by Best Doctors, Inc.